Masako Ueda
- Accounting top 2%
- Private Equity and Venture Capital 11
- Corporate Finance and Governance 10
- Economics and Econometrics top 5%
- Firm Innovation and Growth 5
- Innovation Policy and R&D 4
- Biochemistry top 10%
- Finance top 10%
- Financial Markets and Investment Strategies 3
-
- Lipid metabolism and disorders 7
-
- Lipoproteins and Cardiovascular Health 4
-
- Caveolin-1 and cellular processes 3
Masako Ueda
46 papers receiving 1.0k citations
Peers
Comparison fields: 5 of 118
- Accounting 474
- Management of Technology and Innovation 164
- Economics and Econometrics 325
- Biochemistry 80
- Finance 79
Countries citing papers authored by Masako Ueda
This map shows the geographic impact of Masako Ueda's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Masako Ueda with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Masako Ueda more than expected).
Fields of papers citing papers by Masako Ueda
This network shows the impact of papers produced by Masako Ueda. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Masako Ueda. The network helps show where Masako Ueda may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Masako Ueda, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2024 | 0 | |
| 2 | 2021 | 2 | |
| 3 | 2020 | 4 | |
| 4 | 2019 | 0 | |
| 5 | 2019 | 7 | |
| 6 | 2017 | 150 | |
| 7 | 2016 | 5 | |
| 8 | 2016 | 16 | |
| 9 | 2010 | 9 | |
| 10 | 2010 | 16 | |
| 11 | Law & Entrepreneurship: Do Courts Matter? | 2006 | 1 |
| 12 | 2006 | 29 | |
| 13 | 2006 | 9 | |
| 14 | CEO-Firm Match and Principal-Agent Problem | 2005 | 1 |
| 15 | 2005 | 16 | |
| 16 | 2004 | 79 | |
| 17 | 2001 | 20 | |
| 18 | 1997 | 25 | |
| 19 | 1997 | 1 | |
| 20 | Expertise and finance: Mergers motivated by technological change | 1997 | 1 |
About Masako Ueda
Masako Ueda is a scholar working on Accounting, Economics and Econometrics, Management of Technology and Innovation, Periodontics and Language and Linguistics, having authored 52 papers that have together received 1.1k indexed citations. Recurring topics across this work include Private Equity and Venture Capital (11 papers), Corporate Finance and Governance (10 papers), Lipid metabolism and disorders (7 papers), Firm Innovation and Growth (5 papers), Innovation Policy and R&D (4 papers), Lipoproteins and Cardiovascular Health (4 papers), Caveolin-1 and cellular processes (3 papers) and Financial Markets and Investment Strategies (3 papers). The work is most often cited by research in Accounting (474 citations), Management of Technology and Innovation (164 citations), Economics and Econometrics (325 citations), Biochemistry (80 citations) and Finance (79 citations). Masako Ueda has collaborated with scholars based in United States, Japan and United Kingdom. Frequent co-authors include Masayuki Hirukawa, Alan T. Remaley, Richard L. Dunbar, Marcelo Amar, Anna Wolska, Denis Sviridov, Lita A. Freeman, Isa Bernardini, William A. Gahl and Robert Kleta. Their work appears in journals such as Language, Journal of clinical lipidology, The Journal of Pediatrics, Clinical Journal of the American Society of Nephrology and Management Science.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.